logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Keitaro Shimozaki

Department of Gastroenterological Chemotherapy
H指数:12
被引数:456

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study

日本接受 fruquintinib 治疗的转移性结直肠癌患者中，蛋白尿作为早期剂量调整的原因：一项多中心真实世界研究

International Journal of Clinical Oncology
IF2.8
2026-08-270
OAAI
Shohei Udagawa; Chihiro Ishizuka; Hiroki Osumi; Toshiharu Hirose; Natsuko Okita; Hidekazu Hirano; Hirokazu Shoji; Ken Kato; Koichiro Yoshino; Keitaro Shimozaki; Shota Fukuoka; Takeru Wakatsuki; Mariko Ogura; Akira Ooki; Keisho Chin; Kensei Yamaguchi; Atsuo Takashima; Eiji Shinozaki
Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

HER2阳性晚期胃癌患者真实世界中的治疗选择增加和生存改善（2011年至2023年）

Therapeutic Advances in Gastroenterology
IF3.4
2026-04-110
PRE
Keitaro Shimozaki; Akira Ooki; Kaoru Yoshikawa; Koichiro Yoshino; Shohei Udagawa; Hiroki Osumi; Shota Fukuoka; Takeru Wakatsuki; Mariko Ogura; Daisuke Takahari; Eiji Shinozaki; Keisho Chin; Kensei Yamaguchi
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer

HER2阳性胃癌患者中肿瘤内HER2异质性对曲妥珠单抗德鲁替康疗效的临床影响

Gastric Cancer
IF5.1
2026-04-020
OAAI
Koichiro Yoshino; Manabu Takamatsu; Akira Ooki; Keisho Chin; Daisuke Takahari; Hiroki Osumi; Mariko Ogura; Mikako Tamba; Koshiro Fukuda; Keitaro Shimozaki; Shohei Udagawa; Shota Fukuoka; Eiji Shinozaki; Kensei Yamaguchi; Takeru Wakatsuki
Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience

Zolbetuximab联合化疗在Claudin 18亚型2阳性晚期胃癌中的安全性与有效性：真实世界经验的初步报告

Journal of Cancer Research and Clinical Oncology
IF2.8
2025-12-180
OAAI
Keitaro Shimozaki; Akira Ooki; Shota Fukuoka; Hiroki Osumi; Kaoru Yoshikawa; Koichiro Yoshino; Shohei Udagawa; Takeru Wakatsuki; Eiji Shinozaki; Mariko Ogura; Keisho Chin; Kensei Yamaguchi
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort

糖皮质激素在粒细胞集落刺激因子相关大血管血管炎中很少需要：日本癌症中心队列

RHEUMATOLOGY
IF4.4
2025-12-010
PRE
Morita, Yuka; Takeda, Koichi; Osumi, Hiroki; Aoyama, Yosuke; Fukuda, Naoki; Shimozaki, Keitaro; Udagawa, Shohei; Fukuoka, Shota; Ogura, Mariko; Wakatsuki, Takeru; Ooki, Akira; Chin, Keisho; Shinozaki, Eiji; Takano, Toshimi; Shiga, Taro; Yamaguchi, Kensei
Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC

早期较高的血浆瑞戈菲布浓度预示日本结直肠癌患者无进展生存期缩短

CTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
2025-11-040
OAAI
Kobayashi, Kazuo; Wakatsuki, Takeru; Sugiyama, Erika; Shinozaki, Eiji.; Tajima, Masataka; Ogura, Mariko; Chin, Keisho; Ooki, Akira; Osumi, Hiroki; Fukuoka, Shota; Udagawa, Shohei; Shimozaki, Keitaro; Aoyama, Takeshi; Nakano, Yasuhiro; Kawakami, Kazuyoshi; Suzuki, Wataru; Yokokawa, Takashi; Sato, Hitoshi; Yamaguchi, Masakazu; Yamaguchi, Kensei
Impact of early tumor shrinkage on survival outcomes in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan in third- or later-line settings

早期肿瘤缩小对接受曲妥珠单抗德鲁替康治疗的三线或更后线治疗的HER2阳性晚期胃癌患者生存结局的影响

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
IF3.4
2025-04-240
OA
Koshiro Fukuda; Hiroki Osumi; Keitaro Shimozaki; Keisho Chin; Mariko Ogura; Shota Fukuoka; Shohei Udagawa; Koichiro Yoshino; Mikako Tamba; Takeru Wakatsuki; Eiji Shinozaki; Kensei Yamaguchi; Akira Ooki
The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma

FOLFOX治疗晚期食管鳞癌的疗效和安全性

SCIENTIFIC REPORTS
IF3.9
2025-03-070
OAAI
Shiraishi, Kazuhiro; Okada, Mao; Yamamoto, Shun; Matsubara, Yuki; Masuishi, Toshiki; Shimozaki, Keitaro; Yamamoto, Yoshiyuki; Hirose, Suguru; Sugiyama, Keiji; Furuta, Mitsuhiro; Machida, Nozomu; Takahashi, Naoki; Yoshii, Takako; Kito, Yosuke; Tsuzuki, Takao; Boku, Shogen; Tsuchihashi, Kenji; Sugaya, Akinori; Takayama, Toshizo; Komori, Azusa; Mitani, Seiichiro; Matsumoto, Toshihiko; Nishimura, Takashi; Hirata, Kenro
Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

调查2011年至2023年间免疫疗法在HER2阴性晚期胃癌真实世界患者中的作用

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-02-240
OA
Keitaro Shimozaki; Akira Ooki; Koichiro Yoshino; Mikako Tamba; Shohei Udagawa; Hiroki Osumi; Shota Fukuoka; Izuma Nakayama; Takeru Wakatsuki; Mariko Ogura; Daisuke Takahari; Eiji Shinozaki; Keisho Chin; Kensei Yamaguchi
Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study

曲妥珠单抗Deruxtecan和Nivolumab作为HER2-Positive晚期胃癌三线或后线治疗的疗效和安全性: 单机构回顾性研究

gastric cancer
IF3.8
2023-01-012
OAAI
Shimozaki, Keitaro; Nakayama, Izuma; Takahari, Daisuke; Nagashima, Kengo; Yoshino, Koichiro; Fukuda, Koshiro; Fukuoka, Shota; Osumi, Hiroki; Ogura, Mariko; Wakatsuki, Takeru; Ooki, Akira; Shinozaki, Eiji; Chin, Keisho; Yamaguchi, Kensei

研究方向

暂未获取到该数据
K
Kensei Yamaguchi
H 指数:65论文数:921被引数:2.2万
T
Takeru Wakatsuki
H 指数:24论文数:371被引数:2,541
A
Akira Ooki
H 指数:26论文数:197被引数:2,108
H
Hiroki Osumi
H 指数:20论文数:189被引数:1,585
E
Eiji Shinozaki
H 指数:29论文数:345被引数:3,471
M
Mariko Ogura
H 指数:19论文数:208被引数:1,563
I
Izuma Nakayama
H 指数:18论文数:212被引数:1,722
K
Kenro Hirata
H 指数:26论文数:213被引数:2,363
D
Daisuke Takahari
H 指数:32论文数:355被引数:4,587
S
Shohei Udagawa
H 指数:5论文数:43被引数:90